References
- Aranceta J, Perez-Rodrigo C, Serra-Majem L, Bellido D, de la Torre ML, Formiguera X, Moreno B. Prevention of overweight and obesity: a Spanish approach. Public Health Nutrition 10: 1187− 1193, 2007
- Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 52: 1364−1370, 2003
- Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 21: 263−265, 2005
- Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature 404: 644−651, 2000
- Clement K, Langin D. Regulation of inflammation-related genes in human adipose tissue. Journal of Internal Medicine 262: 422−430, 2007
- Cota D, Proulx K, Seeley RJ. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 132: 2158−2168, 2007
- Dong C, Li WD, Geller F, Lei L, Li D, Gorlova OY, Hebebrand J, Amos CI, Nicholls RD, Price RA. Possible genomic imprinting of three human obesity-related genetic loci. American Journal of Human Genetics 76: 427−437, 2005
- Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39: 175−191, 2007
- Gremlich S, Nguyen D, Reymondin D, Hohlfeld P, Vial Y, Witkin SS, Gerber S. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. Journal of Reproductive Immunology 74: 143−151, 2007
- Hangauer DG, Monzingo AF, Matthews BW. An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. Biochemistry 23: 5730−5741, 1984
- Hinterseher I, Bergert H, Kuhlisch E, Bloomenthal A, Pilarsky C, Ockert D, Schellong S, Saeger HD, Krex D. Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm. The Journal of Surgical Research 133: 121−128, 2006
- Lambert JC, Jaffray JY, Michalski JC, Ortonne JP, Paquis V, Saunieres AM. Biochemical and ultrastructural study of two familial cases of Winchester syndrome. Journal de Genetique Humaine 37: 231−236, 1989
- Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, Glucksman MJ, Bahabri S, Meyer BF, Desnick RJ. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nature Genetics 28: 261−265, 2001
- Martinez-Hernandez A, Enriquez L, Moreno-Moreno MJ, Marti A. Genetics of obesity. Public Health Nutrition 10: 1138−1144, 2007
- Mehta S, Farmer JA. Obesity and inflammation: a new look at an old problem. Current Atherosclerosis Reports 9: 134−138, 2007
- Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Research 63: 3987−3990, 2003
- Migrenne S, Magnan C, Cruciani-Guglielmacci C. Fatty acid sensing and nervous control of energy homeostasis. Diabetes & Metabolism 33: 177−182, 2007
- Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science (New York, NY) 284: 1667−1670, 1999
- Nagase H, Barrett AJ, Woessner JF, Jr. Nomenclature and glossary of the matrix metalloproteinases. Matrix (Stuttgart, Germany) 1: 421−424, 1992
- Rouzier C, Vanatka R, Bannwarth S, Philip N, Coussement A, Paquis-Flucklinger V, Lambert JC. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clinical Genetics 69: 271−276, 2006
- Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics (Oxford, England) 22: 1928−1929, 2006
- Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 68: 978−989, 2001
- Wilson SG, Adam G, Langdown M, Reneland R, Braun A, Andrew T, Surdulescu GL, Norberg M, Dudbridge F, Reed PW, Sambrook PN, Kleyn PW, Spector TD. Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort. Eur J Hum Genet 14: 340−348, 2006
- Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. The Journal of Endocrinology 184: 291−318, 2005
- Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Research 62: 6430−6433, 2002
- Zankl A, Bonafe L, Calcaterra V, Di Rocco M, Superti-Furga A. Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clinical Genetics 67: 261−266, 2005
- Zhou G, Zhai Y, Cui Y, Qiu W, Yang H, Zhang X, Dong X, He Y, Yao K, Zhang H, Peng Y, Yuan X, Zhi L, Zhang X, He F. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Human Mutation 28: 1091−1097, 2007